BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 18805414)

  • 1. Enhanced glycolysis induced by mtDNA mutations does not regulate metastasis.
    Ishikawa K; Hashizume O; Koshikawa N; Fukuda S; Nakada K; Takenaga K; Hayashi J
    FEBS Lett; 2008 Oct; 582(23-24):3525-30. PubMed ID: 18805414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reversible regulation of metastasis by ROS-generating mtDNA mutations.
    Ishikawa K; Koshikawa N; Takenaga K; Nakada K; Hayashi J
    Mitochondrion; 2008 Sep; 8(4):339-44. PubMed ID: 18727959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ROS-generating mitochondrial DNA mutations can regulate tumor cell metastasis.
    Ishikawa K; Takenaga K; Akimoto M; Koshikawa N; Yamaguchi A; Imanishi H; Nakada K; Honma Y; Hayashi J
    Science; 2008 May; 320(5876):661-4. PubMed ID: 18388260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel function of mtDNA: its involvement in metastasis.
    Ishikawa K; Hayashi J
    Ann N Y Acad Sci; 2010 Jul; 1201():40-3. PubMed ID: 20649537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced generation of mitochondrial reactive oxygen species in cybrids containing 4977-bp mitochondrial DNA deletion.
    Jou MJ; Peng TI; Wu HY; Wei YH
    Ann N Y Acad Sci; 2005 May; 1042():221-8. PubMed ID: 15965066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Mitochondria theory of tumor metastasis: ROS-generating mtDNA mutations reversibly regulate tumor cell metastasis].
    Ishikawa K; Hayashi J
    Tanpakushitsu Kakusan Koso; 2009 Jan; 54(1):40-8. PubMed ID: 19195224
    [No Abstract]   [Full Text] [Related]  

  • 7. Enhanced ROS production and antioxidant defenses in cybrids harbouring mutations in mtDNA.
    Vives-Bauza C; Gonzalo R; Manfredi G; Garcia-Arumi E; Andreu AL
    Neurosci Lett; 2006 Jan; 391(3):136-41. PubMed ID: 16165271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific mtDNA mutations in mouse carcinoma cells suppress their tumor formation via activation of the host innate immune system.
    Imanishi H; Takibuchi G; Kobayashi T; Ishikawa K; Nakada K; Mori M; Kikkawa Y; Takenaga K; Toyama-Sorimachi N; Hayashi J
    PLoS One; 2013; 8(9):e75981. PubMed ID: 24098752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation of mtDNA-exchanged cybrids for determination of the effects of mtDNA mutations on tumor phenotypes.
    Ishikawa K; Hayashi J
    Methods Enzymol; 2009; 457():335-46. PubMed ID: 19426877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation of trans-mitochondrial mito-mice by the introduction of a pathogenic G13997A mtDNA from highly metastatic lung carcinoma cells.
    Yokota M; Shitara H; Hashizume O; Ishikawa K; Nakada K; Ishii R; Taya C; Takenaga K; Yonekawa H; Hayashi J
    FEBS Lett; 2010 Sep; 584(18):3943-8. PubMed ID: 20674568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Respiratory function decline and DNA mutation in mitochondria, oxidative stress and altered gene expression during aging.
    Wei YH; Wu SB; Ma YS; Lee HC
    Chang Gung Med J; 2009; 32(2):113-32. PubMed ID: 19403001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contribution of somatic mutations in the mitochondrial genome to the development of cancer and tolerance against anticancer drugs.
    Ohta S
    Oncogene; 2006 Aug; 25(34):4768-76. PubMed ID: 16892089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitochondrial DNA mutations regulate metastasis of human breast cancer cells.
    Imanishi H; Hattori K; Wada R; Ishikawa K; Fukuda S; Takenaga K; Nakada K; Hayashi J
    PLoS One; 2011; 6(8):e23401. PubMed ID: 21853128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitochondrial mutations in cancer.
    Brandon M; Baldi P; Wallace DC
    Oncogene; 2006 Aug; 25(34):4647-62. PubMed ID: 16892079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Defective oxidative phosphorylation in thyroid oncocytic carcinoma is associated with pathogenic mitochondrial DNA mutations affecting complexes I and III.
    Bonora E; Porcelli AM; Gasparre G; Biondi A; Ghelli A; Carelli V; Baracca A; Tallini G; Martinuzzi A; Lenaz G; Rugolo M; Romeo G
    Cancer Res; 2006 Jun; 66(12):6087-96. PubMed ID: 16778181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Free radicals-mediated damage in transmitochondrial cells harboring the T14487C mutation in the ND6 gene of mtDNA.
    Gonzalo R; Garcia-Arumi E; Llige D; Marti R; Solano A; Montoya J; Arenas J; Andreu AL
    FEBS Lett; 2005 Dec; 579(30):6909-13. PubMed ID: 16337195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitochondrial cytochrome B gene mutation promotes tumor growth in bladder cancer.
    Dasgupta S; Hoque MO; Upadhyay S; Sidransky D
    Cancer Res; 2008 Feb; 68(3):700-6. PubMed ID: 18245469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation of mice with mitochondrial dysfunction by introducing mouse mtDNA carrying a deletion into zygotes.
    Inoue K; Nakada K; Ogura A; Isobe K; Goto Y; Nonaka I; Hayashi JI
    Nat Genet; 2000 Oct; 26(2):176-81. PubMed ID: 11017072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymorphic mutations in mouse mitochondrial DNA regulate a tumor phenotype.
    Takibuchi G; Imanishi H; Morimoto M; Ishikawa K; Nakada K; Toyama-Sorimachi N; Kikkawa Y; Takenaga K; Hayashi J
    Mitochondrion; 2013 Nov; 13(6):881-7. PubMed ID: 23932994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A specific nuclear DNA background is required for high frequency lymphoma development in transmitochondrial mice with G13997A mtDNA.
    Hashizume O; Yamanashi H; Taketo MM; Nakada K; Hayashi J
    PLoS One; 2015; 10(3):e0118561. PubMed ID: 25738506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.